IT1391663B1 - Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono - Google Patents

Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono

Info

Publication number
IT1391663B1
IT1391663B1 ITMI2008A001982A ITMI20081982A IT1391663B1 IT 1391663 B1 IT1391663 B1 IT 1391663B1 IT MI2008A001982 A ITMI2008A001982 A IT MI2008A001982A IT MI20081982 A ITMI20081982 A IT MI20081982A IT 1391663 B1 IT1391663 B1 IT 1391663B1
Authority
IT
Italy
Prior art keywords
5alphe
reductase
inhibit
enzyme
pharmaceutical
Prior art date
Application number
ITMI2008A001982A
Other languages
English (en)
Inventor
Sergio Baroni
Anna Benedusi
Giammaria Giuliani
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Priority to ITMI2008A001982A priority Critical patent/IT1391663B1/it
Priority to CA2743216A priority patent/CA2743216C/en
Priority to EP09764757.2A priority patent/EP2373302B1/en
Priority to PCT/EP2009/064881 priority patent/WO2010052329A1/en
Priority to US13/128,394 priority patent/US9668984B2/en
Priority to JP2011535128A priority patent/JP5784499B2/ja
Publication of ITMI20081982A1 publication Critical patent/ITMI20081982A1/it
Application granted granted Critical
Publication of IT1391663B1 publication Critical patent/IT1391663B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ITMI2008A001982A 2008-11-10 2008-11-10 Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono IT1391663B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI2008A001982A IT1391663B1 (it) 2008-11-10 2008-11-10 Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono
CA2743216A CA2743216C (en) 2008-11-10 2009-11-10 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
EP09764757.2A EP2373302B1 (en) 2008-11-10 2009-11-10 THE USE OF COMPOUNDS TO INHIBIT 5alpha-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
PCT/EP2009/064881 WO2010052329A1 (en) 2008-11-10 2009-11-10 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
US13/128,394 US9668984B2 (en) 2008-11-10 2009-11-10 Use of compounds to inhibit 5 α-reductase enzyme activity, and pharmaceutical and cosmetic compostions containing them
JP2011535128A JP5784499B2 (ja) 2008-11-10 2009-11-10 ５α−レダクターゼ酵素活性を阻害するための化合物の使用、並びにそれを含有する医薬及び化粧品組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2008A001982A IT1391663B1 (it) 2008-11-10 2008-11-10 Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono

Publications (2)

Publication Number Publication Date
ITMI20081982A1 ITMI20081982A1 (it) 2010-05-11
IT1391663B1 true IT1391663B1 (it) 2012-01-17

Family

ID=41020757

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2008A001982A IT1391663B1 (it) 2008-11-10 2008-11-10 Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono

Country Status (6)

Country Link
US (1) US9668984B2 (it)
EP (1) EP2373302B1 (it)
JP (1) JP5784499B2 (it)
CA (1) CA2743216C (it)
IT (1) IT1391663B1 (it)
WO (1) WO2010052329A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401289B1 (it) * 2010-04-22 2013-07-18 Giuliani Spa Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
EP2407163A1 (en) 2010-07-16 2012-01-18 Giuliani S.p.A. Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them
ITMI20131475A1 (it) 2013-09-06 2015-03-07 Giuliani Spa Composizioni utili nella prevenzione e terapia dei tumori della pelle
JP6200267B2 (ja) * 2013-10-07 2017-09-20 カイゲンファーマ株式会社 ５αレダクターゼ阻害剤
CA3009197A1 (en) 2015-12-31 2017-07-06 Colgate-Palmolive Company Cleansing compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506027D0 (en) 1985-03-08 1985-04-11 Efamol Ltd Pharmaceutical & dietary compositions
JP2894805B2 (ja) * 1990-07-02 1999-05-24 ライオン株式会社 液体頭髪化粧料
JPH11269056A (ja) * 1998-03-24 1999-10-05 Kyowa Hakko Kogyo Co Ltd 化粧料
FR2803749B1 (fr) 2000-01-18 2006-09-22 Pharmascience Lab Utilisation d'au moins un ester gras pour la preparation d'une composition destinee a inhiber l'activite de la 5 alpha-reductase, en pharmacie notamment en dermatologie, en cosmetique et en tant qu'additif alimentaire
IL152904A0 (en) * 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
ITMI20020960A1 (it) * 2002-05-07 2003-11-07 Univ Degli Studi Milano Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale
JP2008088127A (ja) 2006-10-04 2008-04-17 Shiseido Co Ltd ニキビ肌用皮膚外用組成物
JP5122147B2 (ja) * 2007-01-16 2013-01-16 アサヒグループホールディングス株式会社 抗酸化作用を有する２−（２−メチルプロパノイル）フロログルシノール−１，５−ジ−Ｏ−β−Ｄ−グルコピラノシド

Also Published As

Publication number Publication date
ITMI20081982A1 (it) 2010-05-11
JP2012508214A (ja) 2012-04-05
CA2743216A1 (en) 2010-05-14
JP5784499B2 (ja) 2015-09-24
US9668984B2 (en) 2017-06-06
WO2010052329A1 (en) 2010-05-14
EP2373302B1 (en) 2017-09-13
US20110218245A1 (en) 2011-09-08
CA2743216C (en) 2017-10-17
EP2373302A1 (en) 2011-10-12

Similar Documents

Publication Publication Date Title
SMT201500176B (it) Composizioni e metodi per inibire l'espressione ditranstiretina
BR112013014231A2 (pt) composição de higiene pessoal e uso da composição de higiene pessoal
SMT201400055B (it) Composti di tioacetato, composizioni e metodi d'uso
GB2431876B (en) Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions
SMT201400114B (it) Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a
BR112013004914A2 (pt) "composições de pele e métodos de uso das mesmas".
HK1142536A1 (en) Gel useful for the delivery of cosmetic active ingredients
FR2951946B1 (fr) Utilisation d'un hydrolysat peptidique de levure en tant qu'agent actif pour renforcer le cheveu
FR2975004B1 (fr) Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
BRPI0920355A2 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
ZA201301684B (en) Compositions comprising at least one compound containing a carbamoyl sulfonate group and use of the same as tanning agents
BR112013010694A2 (pt) composições antitranspirantes ativas e sua produção
FR2916633B1 (fr) Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1
IT1397247B1 (it) Nuovi agenti regolatori dell'attivita' citochinica
IT1391663B1 (it) Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono
ITTO20110205A1 (it) Composizione cosmetica oppure dermatologica comprendente l'associazione di un miele e di un peptide.
IT1401218B1 (it) Composizione ad attivita' bio-rigenerativa, riparativa ed eutrofizzante.
FR2997299B1 (fr) Association d'extraits de plantes, ingredient actif cosmetique et composition les contenant, et utilisation topique cosmetique
ITMI20050730A1 (it) Preparazione di composizioni con elevata attivita'insetticida
ITMI20051416A1 (it) Composizioni cosmetiche contenenti acido ialuronico e colostro
WO2010017885A3 (en) Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5yl)-3-methyl- penta-2,4-dienoic
ITMI20051273A1 (it) Composizioni in forma di lipogel per uso cosmetico detergente e farmaceutico
FR2958847B1 (fr) Utilisation d'un hydrolysat peptidique de pois en tant qu'agent actif hydratant
ITRM20060346A1 (it) Composizioni ad attivita' antigerminativa processi per ottenere dette composizioni e loro impiego
BR112012016736A2 (pt) composição , formulação farmacêutica e uso da composição"